Tag Archives: cowpea mosaic virus

JIC researcher named Innovator of the Year

Professor George Lomonossoff has won “Most Promising Innovator” and the overall “Innovator of the Year” prize at this year’s national BBSRC Innovator of the Year Awards, for his work with Dr Frank Sainsbury on the development of a system for the rapid production of vaccines and pharmaceutical proteins in plants. The technology allows plants to [...]

Read more

Medicago USA receives third milestone payment from the U.S. Department of Defense

Medicago USA receives third milestone payment from the U.S. Department of Defense

[Medicago Press Release] Innovations developed at the John Innes Centre are part of a Canadian company’s strategy for developing new ways of rapidly producing large quantities of vaccines. Medicago USA Inc recently announced it has received the third milestone payment of US$5.6 million from the Defense Advanced Research Projects Agency (“DARPA”). This is part of the potential US$21M DARPA milestone awards to [...]

Read more

JIC student presents work at the House of Commons

JIC student presents work at the House of Commons

A PhD student from the John Innes Centre recently got the chance to showcase their work to an audience of MPs and leading scientists at the House of Commons.  Alaa Aljabali from the Department of Biological Chemistry was selected for the SET for Britain poster exhibition, organised by The Parliamentary and Scientific Committee.  The aim [...]

Read more

JIC synthetic biology research features on cover of Integrative Biology

JIC synthetic biology research features on cover of Integrative Biology

Science from the John Innes Centre recently featured on the front cover of the journal Integrative Biology, in a special edition focussing on Synthetic Biology. Prof Dave Evans’ group, in collaboration with Prof George Lomonossoff, have been able to chemically modify the Cowpea Mosaic Virus (CPMV) particle with peptides that cause a specific mineralization process.  [...]

Read more

JIC/PBL technology aids in production of avian flu vaccine candidate

JIC/PBL technology aids in production of avian flu vaccine candidate

[Medicago Press Release] Medicago Inc, a Canadian Biotechnology company, is clinically trialling a vaccine to the H5N1 avian influenza virus, produced in part using innovations developed at the John Innes Centre.  Medicago is using virus-like particles (VLPs) in plants to produce the vaccine.  A protein expression system developed by Professor George Lomonossoff and Dr Frank [...]

Read more

PBL / John Innes Centre technology instrumental in Medicago’s flu vaccine production

PBL / John Innes Centre technology instrumental in Medicago’s flu vaccine production

Quebec City, Canada and Norwich, UK, 12 August 2009 – Medicago, JIC (John Innes Centre) and PBL (Plant Bioscience Limited) announced today that Medicago’s outstanding achievement in producing the H1 VLP antigen in only 14 days, as revealed in the Canadian company’s press release on 30th June 2009, was achieved using among other technologies, a [...]

Read more

International cooperation to produce novel animal vaccines from plants

A new project is being launched that will develop a rapid plant-based system to produce and assess the capacity of different proteins to act as vaccines against important diseases of livestock such as avian influenza and blue tongue. The project is a collaboration between the EU and Russia with participation from South Africa and funded [...]

Read more